CIRCULITE® RECEIVES CONDITIONAL IDE APPROVAL FOR SYNERGY® CIRCULATORY SUPPORT SYSTEM FEASIBILITY TRIAL

MINIMALLY-INVASIVE SYSTEM DESIGNED TO REVERSE HEART FAILURE FILLS TREATMENT GAP FOR AMBULATORY CHRONIC HEART FAILURE PATIENTS SADDLE BROOK, NJ (March 5, 2013) CircuLite®, Inc. today announced that it has received conditional approval from the United States Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) for its lead product, the SYNERGY® Circulatory Support […]